Tessera Therapeutics
Lori Sullivan is a seasoned professional in materials management with extensive experience in the pharmaceutical industry. Currently serving as the Sr. Manager of Materials Management at Tessera Therapeutics since April 2023, Lori previously held key positions at Merck as the Legacy Acceleron Integration Lead and at Acceleron Pharma as the Senior Manager of Materials and Supply Chain, where responsibilities included purchasing support for manufacturing, warehouse management, and clinical drug supply coordination. Earlier roles include Purchasing Manager at Acceleron Pharma, Materials Supervisor at Xanthus Pharmaceuticals, and Biogen Idec, as well as Materials Manager at Repligen Corporation.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.